Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Phase II Study of BNC210 in Adults With Post-Traumatic Stress Disorder (PTSD).

NCT02933606 is registered in ClinicalTrials.gov with Bionomics Limited as lead sponsor.

NCT NCT02933606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02933606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Phase II Study of BNC210 in Adults With Post-Traumatic Stress Disorder (PTSD).
Lead sponsor
Bionomics Limited
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2016
Completion date
July 25, 2018
Enrollment
193 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder